In Yesterday's show, WNYC's Brian Lehrer discussed the rise in Clinical Trials participants with the decline of the American economy.
Forbes/AP also covered this issue.
Do you think that its safe for the industry to see a rise in participants because of the slow economy? With fears that Clinical Trials and organizations could be seen as predators, what precautions should organizations take?
Tuesday, January 6, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment